Authors:
Hibberd, AD
Trevillian, PR
Wlodarzcyk, JH
Gillies, AHB
Stein, AM
Sheil, AGR
Disney, APS
Citation: Ad. Hibberd et al., Predialysis immunosuppression is an independent risk factor for some cancers in renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1846-1847
Authors:
Maisonneuve, P
Agodoa, L
Gellert, R
Stewart, JH
Buccianti, G
Lowenfels, AB
Wolfe, RA
Jones, E
Disney, APS
Briggs, D
McCredie, M
Boyle, P
Citation: P. Maisonneuve et al., Incidence and spectrum of dialysis-associated cancer in three continents -Author's reply, AM J KIDNEY, 35(2), 2000, pp. 352-353
Authors:
Maisonneuve, P
Agodoa, L
Gellert, R
Stewart, JH
Buccianti, G
Lowenfels, AB
Wolfe, RA
Jones, E
Disney, APS
Briggs, D
McCredie, M
Boyle, P
Citation: P. Maisonneuve et al., Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study, AM J KIDNEY, 35(1), 2000, pp. 157-165
Citation: Cg. Chew et al., The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients, NEPH DIAL T, 14(8), 1999, pp. 2047-2049
Authors:
Maisonneuve, P
Agodoa, L
Gellert, R
Stewart, JH
Buccianti, G
Lowenfels, AB
Wolfe, RA
Jones, E
Disney, APS
Briggs, D
McCredie, M
Boyle, P
Citation: P. Maisonneuve et al., Cancer in patients on dialysis for end-stage renal disease: an international collaborative study, LANCET, 354(9173), 1999, pp. 93-99